These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 7771918
1. Duration of neuroleptic treatment and prevalence of tardive dyskinesia in late life. Sweet RA, Mulsant BH, Gupta B, Rifai AH, Pasternak RE, McEachran A, Zubenko GS. Arch Gen Psychiatry; 1995 Jun; 52(6):478-86. PubMed ID: 7771918 [Abstract] [Full Text] [Related]
8. Not all that moves is tardive dyskinesia. Khot V, Wyatt RJ. Am J Psychiatry; 1991 May; 148(5):661-6. PubMed ID: 1673323 [Abstract] [Full Text] [Related]
10. Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Woerner MG, Alvir JM, Saltz BL, Lieberman JA, Kane JM. Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112 [Abstract] [Full Text] [Related]
11. Changing epidemiology of tardive dyskinesia: an overview. Jeste DV, Wyatt RJ. Am J Psychiatry; 1981 Mar; 138(3):297-309. PubMed ID: 6110344 [Abstract] [Full Text] [Related]
12. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study. Morgenstern H, Glazer WM. Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845 [Abstract] [Full Text] [Related]
15. Tardive dystonia. Prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric inpatients. Raja M. Eur Arch Psychiatry Clin Neurosci; 1995 Sep; 245(3):145-51. PubMed ID: 7669821 [Abstract] [Full Text] [Related]
16. The prevalence of tardive dyskinesia. Woerner MG, Kane JM, Lieberman JA, Alvir J, Bergmann KJ, Borenstein M, Schooler NR, Mukherjee S, Rotrosen J, Rubinstein M. J Clin Psychopharmacol; 1991 Feb; 11(1):34-42. PubMed ID: 1674949 [Abstract] [Full Text] [Related]
17. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients. Jeste DV, Lacro JP, Palmer B, Rockwell E, Harris MJ, Caligiuri MP. Am J Psychiatry; 1999 Feb; 156(2):309-11. PubMed ID: 9989570 [Abstract] [Full Text] [Related]
18. Neuroleptic-related dyskinesias in children and adolescents. Connor DF, Fletcher KE, Wood JS. J Clin Psychiatry; 2001 Dec; 62(12):967-74. PubMed ID: 11780878 [Abstract] [Full Text] [Related]
19. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions. Dean CE, Kuskowski MA, Caligiuri MP. J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811 [Abstract] [Full Text] [Related]
20. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study. Woods SW, Morgenstern H, Saksa JR, Walsh BC, Sullivan MC, Money R, Hawkins KA, Gueorguieva RV, Glazer WM. J Clin Psychiatry; 2010 Apr; 71(4):463-74. PubMed ID: 20156410 [Abstract] [Full Text] [Related] Page: [Next] [New Search]